Finance

Beta
Lists
CALC:NASDAQ
Calcimedica Inc
$4.75
-10.21%
(-0.54) 1D
Jun 13, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CALC...
Open
$5.29
High
$5.29
Low
$4.31
Mkt. cap
12.91M
Avg. vol.
10.95K
Volume
5.97K
52-wk high
$7.10
52-wk low
$0.44
EPS
-$39.99
Shares outstanding
5.66M
No. of employees
16
Open
$5.29
High
$5.29
Low
$4.31
Mkt. cap
12.91M
Avg. vol.
10.95K
Volume
5.97K
52-wk high
$7.10
52-wk low
$0.44
EPS
-$39.99
Shares outstanding
5.66M
No. of employees
16
News stories
From sources across the web
About Calcimedica Inc
CEO-
Employees16
FoundedJan 1, 2011
HeadquartersLa Jolla, California, United States
SectorPharmaceutical industry
Websitecalcimedica.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4.05M
3.85M
3.11M
3.48M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.57M
1.77M
1.28M
2.13M
Operating expense
6.62M
5.62M
4.38M
5.61M
Total operating expenses
6.62M
5.62M
4.38M
5.61M
Operating income
-6.62M
-5.62M
-4.38M
-5.61M
Other non operating income
769.00K
-2.00M
-6.20M
10.80M
EBT including unusual items
-5.96M
-7.80M
-10.76M
4.98M
EBT excluding unusual items
-5.96M
-7.80M
-10.76M
4.98M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5.96M
-7.80M
-10.76M
4.98M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
220.00K
140.00K
151.00K
106.00K
Interest expense
-324.00K
-326.00K
-325.00K
-319.00K
Net interest expenses
-104.00K
-186.00K
-174.00K
-213.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-6.61M
-5.61M
-4.38M
-5.60M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer